Alex Kang

Alex Kang

Auto-generated profile, based on publicly available information

Alex Kang

Institute for Protein Design, University of Washington, Seattle, WA 98195, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Science
Verified
Journal Article
Open access
JDJ. Dauparas
J. Dauparas
IAI. Anishchenko
I. Anishchenko
NBN. Bennett
N. Bennett
HBH. Bai
H. Bai
RRR. J. Ragotte
R. J. Ragotte
DBD. Baker
D. Baker
Although deep learning has revolutionized protein structure prediction, almost all experimentally characterized de novo protein designs have been generated using physically based approaches such as Rosetta. Here, we describe a deep learning–based protein sequence design method, ProteinMPNN, that has outstanding performance in both in silico and experimental tests. On native protein backbones, ProteinMPNN has a sequence recovery of 52.4% compared with 32.9% for Rosetta. The amino acid sequence at different positions can be coupled between single or multiple chains, enabling application to a wide range of current protein design challenges. We demonstrate the broad utility and high accuracy of ProteinMPNN using x-ray crystallography, cryo–electron microscopy, and functional studies by rescuing previously failed designs, which were made using Rosetta or AlphaFold, of protein monomers, cyclic homo-oligomers, tetrahedral nanoparticles, and target-binding proteins.

19 April 2024 in Science
Verified
Journal Article
Closed access
RKRohith Krishna
Rohith Krishna
JWJue Wang
Jue Wang
WAWoody Ahern
Woody Ahern
PSPascal Sturmfels
Pascal Sturmfels
PVPreetham Venkatesh
Preetham Venkatesh
DBDavid Baker
David Baker
Deep-learning methods have revolutionized protein structure prediction and design but are presently limited to protein-only systems. We describe RoseTTAFold All-Atom (RFAA), which combines a residue-based representation of amino acids and DNA bases with an atomic representation of all other groups to model assemblies that contain proteins, nucleic acids, small molecules, metals, and covalent modifications, given their sequences and chemical structures. By fine-tuning on denoising tasks, we developed RFdiffusion All-Atom (RFdiffusionAA), which builds protein structures around small molecules. Starting from random distributions of amino acid residues surrounding target small molecules, we designed and experimentally validated, through crystallography and binding measurements, proteins that bind the cardiac disease therapeutic digoxigenin, the enzymatic cofactor heme, and the light-harvesting molecule bilin.

1 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
IAIvan Anishchenko
Ivan Anishchenko
SPSamuel J. Pellock
Samuel J. Pellock
TCTamuka M. Chidyausiku
Tamuka M. Chidyausiku
TRTheresa A. Ramelot
Theresa A. Ramelot
SOSergey Ovchinnikov
Sergey Ovchinnikov
DBDavid Baker
David Baker

15 September 2022 in Science
Verified
Journal Article
Open access
BWB. I. M. Wicky
B. I. M. Wicky
LML. F. Milles
L. F. Milles
ACA. Courbet
A. Courbet
RRR. J. Ragotte
R. J. Ragotte
JDJ. Dauparas
J. Dauparas
DBD. Baker
D. Baker
Deep learning generative approaches provide an opportunity to broadly explore protein structure space beyond the sequences and structures of natural proteins. Here, we use deep network hallucination to generate a wide range of symmetric protein homo-oligomers given only a specification of the number of protomers and the protomer length. Crystal structures of seven designs are very similar to the computational models (median root mean square deviation: 0.6 angstroms), as are three cryo–electron microscopy structures of giant 10-nanometer rings with up to 1550 residues and C 33 symmetry; all differ considerably from previously solved structures. Our results highlight the rich diversity of new protein structures that can be generated using deep learning and pave the way for the design of increasingly complex components for nanomachines and biomaterials.

18 April 2025 in Science
Verified
Journal Article
Closed access
ALAnna Lauko
Anna Lauko
SPSamuel J. Pellock
Samuel J. Pellock
KSKiera H. Sumida
Kiera H. Sumida
IAIvan Anishchenko
Ivan Anishchenko
DJDavid Juergens
David Juergens
DBDavid Baker
David Baker
The design of enzymes with complex active sites that mediate multistep reactions remains an outstanding challenge. With serine hydrolases as a model system, we combined the generative capabilities of RFdiffusion with an ensemble generation method for assessing active site preorganization at each step in the reaction to design enzymes starting from minimal active site descriptions. Experimental characterization revealed catalytic efficiencies ( k cat / K m ) up to 2.2 × 10 5 M −1 s −1 and crystal structures that closely match the design models (Cα root mean square deviations <1 angstrom). Selection for structural compatibility across the reaction coordinate enabled identification of new catalysts remove with five different folds distinct from those of natural serine hydrolases. Our de novo approach provides insight into the geometric basis of catalysis and a roadmap for designing enzymes that catalyze multistep transformations.

15 January 2025 in Nature
Verified
Journal Article
Open access
PDF file
STSusana Vázquez Torres
Susana Vázquez Torres
MBMelisa Benard-Valle
Melisa Benard-Valle
Stephen MackessyStephen Mackessy
Stephen Mackessy
SMStefanie Menzies
Stefanie Menzies
NCNicholas Casewell
Nicholas Casewell
DBDavid Baker
David Baker
Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 lives annually and causing severe complications and long-lasting disabilities for many more1,2. Three-finger toxins (3FTx) are highly toxic components of elapid snake venoms that can cause diverse pathologies, including severe tissue damage3 and inhibition of nicotinic acetylcholine receptors, resulting in life-threatening neurotoxicity4. At present, the only available treatments for snakebites consist of polyclonal antibodies derived from the plasma of immunized animals, which have high cost and limited efficacy against 3FTxs5,6,7. Here we used deep learning methods to de novo design proteins to bind short-chain and long-chain α-neurotoxins and cytotoxins from the 3FTx family. With limited experimental screening, we obtained protein designs with remarkable thermal stability, high binding affinity and near-atomic-level agreement with the computational models. The designed proteins effectively neutralized all three 3FTx subfamilies in vitro and protected mice from a lethal neurotoxin challenge. Such potent, stable and readily manufacturable toxin-neutralizing proteins could provide the basis for safer, cost-effective and widely accessible next-generation antivenom therapeutics. Beyond snakebite, our results highlight how computational design could help democratize therapeutic discovery, particularly in resource-limited settings, by substantially reducing costs and resource requirements for the development of therapies for neglected tropical diseases.